Table 4 Comparison of surgical conditions and clinical outcomes between type 1 and type 2
Parameters | Type 1(n = 86) | Type 2 (n = 45) | P |
|---|---|---|---|
Treated by Lauromacrogol(%) | 0.651 | ||
No | 36 (41.9) | 17 (37.8) | |
Yes | 50 (58.1) | 28 (62.2) | |
Hemoglobin change(g/L) | 11.0 (4.0, 18.0) | 11.0 (7.0, 16.0) | 0.737 |
Hospital day | 5.1 ± 1.1 | 5.3 ± 1.1 | 0.323 |
Hospital stay cost (¥) | 7764.1 ± 1767.3 | 8010.2 ± 1880.2 | 0.464 |
Intraoperative blood loss (ml) | 17.5 (10.0, 20.0) | 20.0 (10.0, 40.0) | 0.138 |
Operating time (min) | 28.8 ± 12.2 | 31.5 ± 25.0 | 0.407 |
Time to β-hCG normalization (days) | 28.7 ± 9.0 | 28.6 ± 9.7 | 0.973 |
Uterine packing rate (%) | 5 (5.8) | 4 (8.9) | 0.493 |
Complications (%) | 20 (23.3) | 16 (35.6) | 0.134 |
Cure rate (%) | 86 (100) | 43 (95.6) | 0.116 |